PCN62 COST ANALYSIS OF HORMONE RECEPTOR POSITIVE, ADVANCED BREAST CANCER TREATMENT WITH ENDOCRINE THERAPY VERSUS CHEMOTHERAPY IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM (BPHS)

Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74313-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)74313-8/fulltext
Title : PCN62 COST ANALYSIS OF HORMONE RECEPTOR POSITIVE, ADVANCED BREAST CANCER TREATMENT WITH ENDOCRINE THERAPY VERSUS CHEMOTHERAPY IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM (BPHS)
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74313-8&doi=10.1016/S1098-3015(10)74313-8
First page :
Section Title :
Open access? : No
Section Order : 239
Categories :
Tags :
Regions :
ViH Article Tags :